Haigang Chen

This inventor holds 8 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Aponia Laboratories, Inc., Dow Pharmaceutical Sciences, Inc., Xenon Pharmaceuticals Inc.. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haigang Chen. Retrieved from https://idiyas.com/inventor/haigang-chen-8csbhyjg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 53(Granted Patents)

Location History:

Petaluma, CA (US) (2011 - 2014)
Edina, MT (US) (2014)
Plymouth, MN (US) (2016)
Edina, MN (US) (2015 - 2022)

Company Filing History:

4 out of 4

Aponia Laboratories, Inc.

patents

3 out of 48

Dow Pharmaceutical Sciences, Inc.

patents

1 out of 110

Xenon Pharmaceuticals Inc.

patents

Years Active: 2011-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11419814 - Transdermal compositions of ibuprofen and methods of use thereof (2022-08-23),

2. 10821071 - Transdermal compositions of ibuprofen and methods of use thereof (2020-11-03),

3. 9849080 - Transdermal compositions of ibuprofen and methods of use thereof (2017-12-26),

4. 9504671 - Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents (2016-11-29),

5. 9205041 - Transdermal compositions of ibuprofen and methods of use thereof (2015-12-08),

6. 8877792 - Compositions for increasing solubility of azole drug compounds that are poorly soluble in water (2014-11-04),

7. 8658678 - Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water (2014-02-25),

8. 7893097 - Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water (2011-02-22),

Title: Haigang Chen: Innovator in Transdermal Drug Delivery

Introduction

Haigang Chen is a notable inventor based in Edina, MN (US). He has made significant contributions to the field of transdermal drug delivery, holding a total of 8 patents. His work focuses on innovative compositions that enhance the effectiveness of medications.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Transdermal compositions of ibuprofen and methods of use thereof." This patent describes a transdermal composition that includes ibuprofen or its salts combined with a gelling agent. This formulation is designed to treat various disorders such as pain, inflammation, arthritis, muscle spasms, and associated symptoms in both humans and animals.

Career Highlights

Haigang Chen has worked with reputable companies in the pharmaceutical industry, including Aponia Laboratories, Inc. and Dow Pharmaceutical Sciences, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.

Collaborations

Throughout his career, Haigang has collaborated with talented individuals such as Gareth Winckle and Christopher Riley. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Haigang Chen's contributions to transdermal drug delivery highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing pain and inflammation through advanced pharmaceutical compositions.

Profile summary based on public USPTO records.